Applied Filters
LSIPR 50 2018: Sung Yunmo
Sung Yunmo was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.
LSIPR 50 2018: Levelling the medicines playing field
Speaking to LSIPR Leena Menghaney, regional head of Médecins Sans Frontières’ Access Campaign in South Asia, explains the importance of a balanced IP policy in fostering healthy generic competition.
Protecting patients, and patents
Drug companies can take heart from a range of best practices in the battle against counterfeit medicines, as LSIPR finds out.
Regulation and licensing: the CRISPR conundrum continues
As innovation in the CRISPR field continues across the world, questions are being asked about the role of regulating such a powerful tool, while discussions around licensing the technology continue, as LSIPR reports.
Uncertain times for antibodies in India
In India, there are two core areas of the antibody patenting field that are unsettled and need correcting, as Archana Shanker and Nupur Maithani of Anand and Anand explain.
Patents and biodiversity: crossing the divide
The Indian Patent Office has attempted to bridge the divide between the laws on patents and biological diversity, but instead it created a maze of problems, says Vidisha Garg of Anand and Anand.
Clearing a way through the CRISPR patent jungle
There may be a path through the CRISPR patent jungle, but there are many obstacles still in the way, say European academics Timo Minssen, Esther van Zimmeren and Jakob Wested.
Conference preview: ChinaBio Partnering Forum
The ChinaBio Partnering Forum, which will be held in Suzhou from April 25 to 26, is celebrating its tenth anniversary and is expected to attract pharma and biotech companies from around the world.
LSIPR 50 2017: Gyanendra Nath Singh and Krishnaswamy VijayRaghavan
Gyanendra Nath Singh and Krishnaswamy VijayRaghavan were selected in the LSIPR 50 2017 publication for their influence on the life sciences industry. They featured in the government and policy section, as LSIPR reports.
LSIPR 50 2017: Yasuhisa Shiozaki
Yasuhisa Shiozaki was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.
